CD64, a reliable biomarker of bacterial infection in intensive care units?

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 10, 2012, Pages 1058-

  Roussel, Mikael ^a   Gros, Antoine ^a   Sauvadet, Elise ^a   Gacouin, Arnaud ^a   Marqué, Sophie ^a   Chimot, Loic ^a   Lavoué, Sylvain ^a   Camus, Christophe ^a   Fest, Thierry ^a   Le Tulzo, Yves ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD64 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BLOOD SAMPLING; FALSE NEGATIVE RESULT; HUMAN; INTENSIVE CARE UNIT; LETTER; PRIORITY JOURNAL; ROOM TEMPERATURE; SEPSIS;

EID: 84869217118     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.186.10.1058     Document Type: Letter

References (3)

1. Gibot S, Bene MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho Bittencourt M, Quenot J-P, Bollaert P-E, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012;186:65-71.
2. Gros A, RousselM, Sauvadet E, Gacouin A,Marqué S, Chimot L, Lavoué S, Camus C, Fest T, Le Tulzo Y. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med 2012;38:445-452.
3. Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases. Curr Opin Infect Dis 2010;23:268-274.